Sunday, April 20, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

937 POSTS 0 COMMENTS
Research

Mustang Bio (MBIO) $3.40 Gets $7 Price Target from Cantor. (SeekingAlpha.)

Editor / Curator -
redefy
IPOS

Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.

Editor / Curator -
orchestra biomed
Biotech News

Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation.

Editor / Curator -
ecuador gold
Precious Metals

Ecuador: The Largest Gold Rush in History? Initiating Coverage on Lucky...

Editor / Curator -
Institutional Gold Research
Precious Metals

Is Gold $50 Away From a Domino Effect From a Flood...

Editor / Curator -
hotel communication network
Internet News

HCN to Showcase how Hotels can Save up to $50 per...

Editor / Curator -
BDC

Owl Rock Capital Corp. II Files for Best-Efforts IPO (S&P Global)

Editor / Curator -
biotech stock review
All News

Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & ...

Editor / Curator -
internet stock review
Stand Down.

Stand Down II: Will a Collapse in the Stock Market Spark...

Editor / Curator -
NanoVobronix, Biotech Stock Review
Biotech News

NanoVibronix (NAOV) $3.13 Announces CBD Patch and Cream for PainShield®

Editor / Curator -
1...828384...94Page 83 of 94

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator -
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.